A phase 2 study of venetoclax plus R-CHOP as first-line treatment for patients with diffuse large B-cell lymphoma.

Morschhauser, F; Feugier, P; Flinn, IW; Gasiorowski, R; Greil, R; Illes, A; Johnson, NA; Larouche, JF; Lugtenburg, PJ; Patti, C; Salles, GA; Trneny, M; de Vos, S; Mir, F; Samineni, D; Kim, SY; Jiang, YW; Punnoose, E; Sinha, A; Clark, E; Spielewoy, N; Humphrey, K; Bazeos, A; Zelenetz, AD

View this publication in the PUBMED database